- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-6194 in Adult Participants with Non-Segmental Vitiligo.
This study is testing a new medicine, MK-6194, for adults with a type of vitiligo called non-segmental vitiligo. Researchers want to see if the medicine can help reduce white patches on the face and if it's safe to use, compared to a dummy medicine.
For: Non segmental vitiligoBelgium · Germany · Spain - Ongoing, recruitingPhase II and Phase III (Integrated)
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus
This study is looking into a new medicine called MK-6194 for adults with lupus (Systemic Lupus Erythematosus). It compares the new medicine to a dummy medicine (placebo) to see if it helps improve lupus symptoms and if it's safe to use.
For: Systemic Lupus ErythematosusFrance · Spain · Poland